Immunotargeting relapsed or refractory precursor B-cell acute lymphoblastic leukemia - role of blinatumomab

Queudeville, Manon; Handgretinger, Rupert; Ebinger, Martin

dc.contributor.author	Queudeville, Manon
dc.contributor.author	Handgretinger, Rupert
dc.contributor.author	Ebinger, Martin
dc.date.accessioned	2018-05-30T14:11:50Z
dc.date.available	2018-05-30T14:11:50Z
dc.date.issued	2017
dc.identifier.issn	1178-6930
dc.identifier.uri	http://hdl.handle.net/10900/82089
dc.language.iso	en	de_DE
dc.publisher	Dove Medical Press Ltd	de_DE
dc.relation.uri	http://dx.doi.org/10.2147/OTT.S103470	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	570	de_DE
dc.subject.ddc	610	de_DE
dc.title	Immunotargeting relapsed or refractory precursor B-cell acute lymphoblastic leukemia - role of blinatumomab	de_DE
dc.type	Article	de_DE
utue.quellen.id	20170815222223_02130
utue.publikation.seiten	3567-3578	de_DE
utue.personen.roh	Queudeville, Manon
utue.personen.roh	Handgretinger, Rupert
utue.personen.roh	Ebinger, Martin
dcterms.isPartOf.ZSTitelID	Oncotargets and Therapy	de_DE
dcterms.isPartOf.ZS-Volume	10	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE